Join to View Full Profile
3350 Main StSpringfield, MA 01107
Phone+1 413-794-9338
Fax+1 413-794-9754
Dr. McCann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995- Tufts Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Massachusetts Medical SchoolClass of 1988
Certifications & Licensure
MA State Medical License 1990 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2011, 2013-2015, 2017
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2011, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2011, 2013-2015, 2017
Clinical Trials
- Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2005 Aug 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
Publications & Presentations
PubMed
- 46 citationsPemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani, Joel N. Saltzman, Nathan A. Pennell
Journal of Clinical Oncology. 2019-07-30 - 19 citationsA combination of mild hypothermia and sevoflurane affords long-term protection in a modified neonatal mouse model of cerebral hypoxia-ischemia.Erica P. Lin, Lili Miles, Elizabeth A. Hughes, John McCann, Charles V. Vorhees
Anesthesia and Analgesia. 2014-11-01 - 78 citationsCharacterization and quantification of isoflurane-induced developmental apoptotic cell death in mouse cerebral cortex.George K. Istaphanous, Christopher G. Ward, Xinyu Nan, Elizabeth A. Hughes, John McCann
Anesthesia and Analgesia. 2013-03-04
Press Mentions
Getting Answers: Risks of Lung Cancer in Non-SmokersDecember 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
